Inspiratory Muscle Training With Normocapnic Hyperpnea in Chronic Obstructive Pulmonary Disease (COPD)

NCT01218295 | Unknown

• 1 other identifier: IMTCOPD2
• Study Type: interventional
• Target: 20
• Locations: 1 country
• Sites: 1

Brief Summary

Many studies suggest that inspiratory muscles training by means of normocapnic hyperpnea improves exercise tolerance in healthy subjects. No information is available about the use of this training in COPD patients even if other methods (such as threshold loading and resistive loading) have been shown to be effective in terms of Inspiratory Muscle Function, Health-Related Quality of Life and Exercise Tolerance. This study is designed to evaluate the effects of normocapnic hyperventilation by means of Spirotiger®, an instrument training the respiratory muscles, avoiding hypocapnia (using the methodology of isocapnic hyperpnoea)in COPD patients.

Conditions

COPD

Keywords

COPD; inspiratory muscles training

Outcome Measures

Primary Outcomes (1)

• Exercise Capacity

  1 month

Study Arms (1)

Respiratory muscle training

EXPERIMENTAL

Patients assigned to this arm train the respiratory muscles by means of normocapnic hyperpnea.

Device: Spirotiger®

Interventions

Spirotiger® DEVICE

training session :10 minutes twice a day X 4 weeks

Also known as: Pulmonary rehabilitation

Respiratory muscle training

Eligibility Criteria

• Age: 40 Years - 85 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• COPD patients. All patients are at stable state, free from an exacerbation from at least 3 months.

You may not qualify if:

• COPD patients with a recent history of cardiovascular disease, neurologic disease and other diseases that would interfere with the training.

Sponsors & Collaborators

• Università degli Studi di Ferrara: lead

Study Sites (1)

Pulmonary Respiratory Unit- University Hospital

Ferrara, Ferrara, 44100, Italy

RECRUITING

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Annalisa Cogo, MD

  Università di Ferrara

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Annalisa Cogo, MD

CONTACT

+390532210420; cga@unife.it

Luca Pomidori, PhD

CONTACT

+390532455888; pmdlcu@unife.it

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: October 7, 2010
• First Posted: October 11, 2010
• Study Start: May 1, 2009
• Primary Completion: June 1, 2011
• Study Completion: July 1, 2011
• Last Updated: October 11, 2010

Record last verified: 2010-10

Locations

IT (1)